The regulation of PD-L1 levels is controlled by proteasome-mediated degradation, influenced by CDK4/6 and Cullin 3SPOP E3 ligase, where blocking the phosphorylation of SPOP can increase PD-L1 expression in primary prostate cancer specimens. Here, SPOP is linked to prostate carcinoma.